Profound Medical Corp (NAS:PROF)
$ 7.15 0.1 (1.42%) Market Cap: 209.63 Mil Enterprise Value: 188.61 Mil PE Ratio: 0 PB Ratio: 5.93 GF Score: 73/100

Profound Medical Corp at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 08:55PM GMT
Release Date Price: $10.02 (+1.21%)
Unidentified Analyst Cantor Fitzgerald
L.P. - Analyst

And the privilege of hosting, Arun Menawat, from Profound Medical. Arun, I'll leave it to you. Thank you.

Arun Menawat
Profound Medical Corp. - CEO and Chairman of the Board

Perfect. Thank you so much. You know the tag line for our company, Profound Medical, is incision-free ablation. And incision-free is a very big thing in the sense that we're finally doing surgery without any incision, which means no hospital stay, daytime procedure, hours of recovery rather than days of recovery, and we're able to treat very serious prostate cancer patients.

So this is a company. We're building an entirely new platform, which allows us to really move robotics to incision-free robotics. And our robotics is not the master slave robotics. It is actually autonomous robotics. So I'm going to go through some of that.

And the other word that's interesting in our tag line is with vision. We use a real-time MRI. So we are actually doing serious intervention in the MRI on a routine basis.

So as I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot